Bayer Pharma continues to boost its presence in the Asia-Pacific
2015 regional revenue rises 7% to 4b euros; clinical trials triple in 9 years
Nisha Ramchandani
Singapore
The number of clinical trials conducted by Bayer Pharmaceuticals in Asia Pacific has more than tripled since 2007 - from 21 to 68 - as the healthcare group strengthens its focus on the region.
Here in Singapore, the number of trials has expanded nearly fourfold to 22 from six in the same time frame.
TRENDING NOW
UOB CEO’s youngest child Grant Wee turns burnout into a wellness business
Trump holds off on major escalation against Iran amid fears over dwindling US missile interceptor stockpiles
SK Hynix tycoon ordered to pay US$643 million divorce settlement
Singapore banks’ battle for wealth talent goes beyond private bankers